![Charles Romp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Romp
Direktor/Vorstandsmitglied bei
CELCUITY INC.
Vermögen: 231 876 $ am 31.05.2026
Profil
Charles R.
Romp is President, Chief Executive Officer & Director at Secura Bio, Inc. since 2024.
Mr. Romp is an Independent Director at Celcuity, Inc. starting in 2026.
Former roles include Executive Vice President-Commercial at Seagen, Inc. from 2020 to 2023, Sales Director at Avastin, Product Manager at GE Medical Systems, Inc. from 1997 to 1998, and Pharmaceutical Sales Representative at GlaxoSmithKline LLC.
Education includes an MBA from Saint Leo University, Inc. and undergraduate studies at the University of Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 1.745 ( 0 % ) | 231 876 $ | 31.05.2026 |
Aktive Positionen von Charles Romp
| Unternehmen | Position | Beginn |
|---|---|---|
| CELCUITY INC. | Direktor/Vorstandsmitglied | 11.02.2026 |
Secura Bio, Inc.
 Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Vorstandsvorsitzender | 15.10.2024 |
Ehemalige bekannte Positionen von Charles Romp
| Unternehmen | Position | Ende |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 14.12.2023 |
GE Medical Systems, Inc.
 GE Medical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic imaging and medical monitoring systems as well as provides information technology services to health care providers | Corporate Officer/Principal | 01.01.1998 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Avastin | Vertrieb & Marketing | - |
Ausbildung von Charles Romp
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
GE Medical Systems, Inc.
GE Medical Systems, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic imaging and medical monitoring systems as well as provides information technology services to health care providers | Health Technology |
Saint Leo University, Inc.
 Saint Leo University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Avastin | |
Celcuity, Inc.
 Celcuity, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company develops novel diagnostic tests | Health Technology |
Secura Bio, Inc.
Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Health Technology |
